{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:30:09Z","timestamp":1759969809222,"version":"build-2065373602"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272411","82472356"],"award-info":[{"award-number":["82272411","82472356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Medical Key Discipline","award":["ZDXK202240"],"award-info":[{"award-number":["ZDXK202240"]}]},{"DOI":"10.13039\/501100004610","name":"Science and Technology Project of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2023741"],"award-info":[{"award-number":["BE2023741"]}],"id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Jiangsu Province Research Hospital","award":["YJXYY202204-XKB16"],"award-info":[{"award-number":["YJXYY202204-XKB16"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Gastric cancer (GC) is globally recognized as one of the most widespread malignant tumors. As the symptoms of patients with early GC are ambiguous, the majority of patients are given a diagnosis of advanced GC. Therefore, this necessitates the search for new biomarkers to be utilized in the early diagnosis and screening of GC. Enhancer RNA (eRNA) is a non-coding RNA in transcription by enhancers that is tumor-specific and has a critical function in cancer progression. Our research investigates new eRNAs as bio-diagnostic markers for GC. Four eRNAs with good differential expression in GC were screened by TCGA and University of California, Santa Cruz databases. Quantitative real-time PCR was utilized for testing the level of RASSF8-AS1. The diagnostic effect of RASSF8-AS1 was evaluated using the receiver operating characteristic (ROC). Functional experiments were used to detect the ability of RASSF8-AS1 to affect the metastasis and proliferation in GC cells. The expression of RASSF8-AS1 was obviously elevated in both GC tissues and serum, whereas it was decreased in the serum levels of postoperative GC patients. ROC showed that RASSF8-AS1 was more diagnostically efficient than common diagnostic biomarkers for GC and that diagnostic effectiveness could be better than combining them. The findings of in vitro experiments showed that knocking down the level of RASSF8-AS1 clearly suppressed the ability of growth and metastasis in GC cells. Studies have shown that serum RASSF8-AS1 has the potential to contribute to the progression of GC as a biomarker for diagnosis and prognostic monitoring of GC.<\/jats:p>","DOI":"10.1093\/carcin\/bgaf050","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T19:23:20Z","timestamp":1756236200000},"source":"Crossref","is-referenced-by-count":0,"title":["A novel serum biomarker Enhancer RNA RASSF8-AS1 promotes the progression of gastric cancer"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7640-4608","authenticated-orcid":false,"given":"Xun","family":"Li","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]},{"name":"Medical School of Nantong University, Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]},{"name":"Research Center of Clinical Medicine, Affiliated Hospital of Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Affiliated Hospital of Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bairong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]},{"name":"Medical School of Nantong University, Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]},{"name":"Research Center of Clinical Medicine, Affiliated Hospital of Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinliang","family":"Gu","sequence":"additional","affiliation":[{"name":"General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University , Nanjing, Jiangsu 210008 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyu","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]},{"name":"Medical School of Nantong University, Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]},{"name":"Research Center of Clinical Medicine, Affiliated Hospital of Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjuan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7448-2020","authenticated-orcid":false,"given":"Shaoqing","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University , Nantong, Jiangsu 226001 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2025100804314681700_bgaf050-B1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"2025100804314681700_bgaf050-B2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000506509","article-title":"Gastric cancer: where are we heading?","volume":"38","author":"Petryszyn","year":"2020","journal-title":"Dig Dis"},{"key":"2025100804314681700_bgaf050-B3","doi-asserted-by":"publisher","first-page":"f6367","DOI":"10.1136\/bmj.f6367","article-title":"The diagnosis and management of gastric cancer","volume":"347","author":"Thrumurthy","year":"2013","journal-title":"BMJ"},{"key":"2025100804314681700_bgaf050-B4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/annonc\/mdw040","article-title":"Molecular classification of gastric cancer","volume":"27","author":"Chia","year":"2016","journal-title":"Ann Oncol"},{"key":"2025100804314681700_bgaf050-B5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","article-title":"Burden of gastric cancer","volume":"18","author":"Thrift","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025100804314681700_bgaf050-B6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10120-013-0259-5","article-title":"Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association","volume":"17","author":"Shimada","year":"2014","journal-title":"Gastric Cancer"},{"key":"2025100804314681700_bgaf050-B7","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3748\/wjg.v25.i11.1378","article-title":"Early gastric cancer diagnostic ability of ultrathin endoscope loaded with laser light source","volume":"25","author":"Suzuki","year":"2019","journal-title":"World J Gastroenterol"},{"key":"2025100804314681700_bgaf050-B8","doi-asserted-by":"publisher","first-page":"e1003569","DOI":"10.1371\/journal.pgen.1003569","article-title":"Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs","volume":"9","author":"Hangauer","year":"2013","journal-title":"PLoS Genet"},{"key":"2025100804314681700_bgaf050-B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-genet-110711-155459","article-title":"Noncoding transcription at enhancers: general principles and functional models","volume":"46","author":"Natoli","year":"2012","journal-title":"Annu Rev Genet"},{"key":"2025100804314681700_bgaf050-B10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrg.2016.4","article-title":"Enhancers as non-coding RNA transcription units: recent insights and future perspectives","volume":"17","author":"Li","year":"2016","journal-title":"Nat Rev Genet"},{"key":"2025100804314681700_bgaf050-B11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s43018-020-00135-y","article-title":"CDK4\/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity","volume":"2","author":"Watt","year":"2021","journal-title":"Nat Cancer"},{"key":"2025100804314681700_bgaf050-B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20040311","article-title":"Charting gene regulatory networks: strategies, challenges and perspectives","volume":"381","author":"Wei","year":"2004","journal-title":"Biochem J"},{"key":"2025100804314681700_bgaf050-B13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/cells8101281","article-title":"Enhancer dysfunction in 3D genome and disease","volume":"8","author":"Xia","year":"2019","journal-title":"Cells"},{"key":"2025100804314681700_bgaf050-B14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.celrep.2016.03.038","article-title":"Activation of P-TEFb by androgen receptor-regulated enhancer RNAs in castration-resistant prostate cancer","volume":"15","author":"Zhao","year":"2016","journal-title":"Cell Rep"},{"key":"2025100804314681700_bgaf050-B15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/cancers11030347","article-title":"AP001056.1, a prognosis-related enhancer RNA in squamous cell carcinoma of the head and neck","volume":"11","author":"Gu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2025100804314681700_bgaf050-B16","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1042\/EBC20200014","article-title":"Enhancer RNA: biogenesis, function, and regulation","volume":"64","author":"Ye","year":"2020","journal-title":"Essays Biochem"},{"key":"2025100804314681700_bgaf050-B17","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1038\/s41467-019-12543-5","article-title":"Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"2025100804314681700_bgaf050-B18","doi-asserted-by":"publisher","first-page":"e29759","DOI":"10.1097\/MD.0000000000029759","article-title":"Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2025100804314681700_bgaf050-B19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.7150\/thno.78687","article-title":"Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m(6)A modification","volume":"13","author":"Zhao","year":"2023","journal-title":"Theranostics"},{"key":"2025100804314681700_bgaf050-B20","doi-asserted-by":"publisher","first-page":"113754","DOI":"10.1016\/j.yexcr.2023.113754","article-title":"A mutator-derived prognostic eRNA signature provides insight into the pathogenesis of breast cancer","volume":"431","author":"Wang","year":"2023","journal-title":"Exp Cell Res"},{"key":"2025100804314681700_bgaf050-B21","doi-asserted-by":"publisher","first-page":"105075","DOI":"10.1016\/j.isci.2022.105075","article-title":"The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance","volume":"25","author":"Hu","year":"2022","journal-title":"iScience"},{"key":"2025100804314681700_bgaf050-B22","doi-asserted-by":"publisher","first-page":"102629","DOI":"10.1016\/j.ctrv.2023.102629","article-title":"Regulatory T cells in gastric cancer: key controllers from pathogenesis to therapy","volume":"120","author":"Negura","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"2025100804314681700_bgaf050-B23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"2025100804314681700_bgaf050-B24","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3748\/wjg.v24.i26.2818","article-title":"Biomarkers of gastric cancer: current topics and future perspective","volume":"24","author":"Matsuoka","year":"2018","journal-title":"World J Gastroenterol"},{"key":"2025100804314681700_bgaf050-B25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"2025100804314681700_bgaf050-B26","doi-asserted-by":"publisher","first-page":"11582","DOI":"10.3390\/ijms231911582","article-title":"Enhancer RNA (eRNA) in human diseases","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025100804314681700_bgaf050-B27","doi-asserted-by":"publisher","first-page":"e13202","DOI":"10.1111\/cpr.13202","article-title":"Enhancer RNA: what we know and what we can achieve","volume":"55","author":"Han","year":"2022","journal-title":"Cell Prolif"},{"key":"2025100804314681700_bgaf050-B28","doi-asserted-by":"publisher","first-page":"743840","DOI":"10.3389\/fonc.2021.743840","article-title":"Enhancer RNA SLIT2 inhibits bone metastasis of breast cancer through regulating P38 MAPK\/c-Fos signaling pathway","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"2025100804314681700_bgaf050-B29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13048-022-00987-1","article-title":"The enhancer RNA ADCY10P1 is associated with the progression of ovarian cancer","volume":"15","author":"Mo","year":"2022","journal-title":"J Ovarian Res"},{"key":"2025100804314681700_bgaf050-B30","doi-asserted-by":"publisher","first-page":"765484","DOI":"10.3389\/fonc.2021.765484","article-title":"SPRY4-AS1, a novel enhancer RNA, is a potential novel prognostic biomarker and therapeutic target for hepatocellular carcinoma","volume":"11","author":"Ye","year":"2021","journal-title":"Front Oncol"},{"key":"2025100804314681700_bgaf050-B31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1186\/s12885-021-08517-w","article-title":"TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma","volume":"21","author":"Cheng","year":"2021","journal-title":"BMC Cancer"},{"key":"2025100804314681700_bgaf050-B32","doi-asserted-by":"publisher","first-page":"e0251515","DOI":"10.1371\/journal.pone.0251515","article-title":"eNEMAL, an enhancer RNA transcribed from a distal MALAT1 enhancer, promotes NEAT1 long isoform expression","volume":"16","author":"Stone","year":"2021","journal-title":"PLoS One"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgaf050\/64141331\/bgaf050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/article-pdf\/46\/3\/bgaf050\/64141331\/bgaf050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/article-pdf\/46\/3\/bgaf050\/64141331\/bgaf050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:31:52Z","timestamp":1759912312000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/doi\/10.1093\/carcin\/bgaf050\/8241993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9,4]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgaf050","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"type":"print","value":"0143-3334"},{"type":"electronic","value":"1460-2180"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,26]]},"article-number":"bgaf050"}}